drugset / Trial / NCT00919113
Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A new device for interstitial cystitis is compared to inactive control to determine if it is safe and effective. The study lasts approximately 7 weeks with a 19-week follow-up period.
Timeline
- Start
- 2009-07
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sodium chondroitin sulfate | Unknown | 2 % | Other |
| Subject | sodium chondroitin sulfate | Unknown | 20 ml | Other |